BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04431635-completion@plaintrial.com
DTSTAMP:20261028T170852Z
DTSTART;VALUE=DATE:20231114
SUMMARY:Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor\, Copanl
 isib Given in Combination With the Immunotherapeutic Agents\, Nivolumab an
 d Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma — est
 imated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04431635
URL:https://plaintrial.com/trial/NCT04431635
END:VEVENT
END:VCALENDAR